Publications by authors named "Jason Steenkamp"

Claim this Profile
C
Comparative efficacy and safety of tislelizumab and other programmed cell death protein 1 inhibitors in first-line treatment of advanced gastroesophageal cancers: a systematic review and network meta-analysis.
Jaffer A Ajani, Maria Alsina, Markus Moehler, Keun-Wook Lee, Wenxi Tang, Jason Steenkamp

Gastric Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Matching-Adjusted Indirect Comparison of Recombinant Factor IX Albumin Fusion Protein Versus Recombinant Factor IX Fc Fusion Protein for Weekly Prophylactic Treatment of Hemophilia B.
Benoit Guillet, Songkai Yan, Becky Hooper, Douglass Drelich, Jason Steenkamp

Adv Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus.
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington

J Comp Eff Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus.
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington

J Comp Eff Res· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab compared with other biologics for the treatment of severe asthma: a systematic review and indirect treatment comparison.
Andrew Menzies-Gow, Jason Steenkamp, Sumeet Singh, Wilma Erhardt, Jennifer Rowell

J Med Econ· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis